Edward L. Murphy, MD, MPH

Research and Clinical Interests

Epidemiology and pathophysiology (health effects) of human T-lymphotropic virus types I and II (HTLV-I and -II)
Epidemiology of transfusion transmitted HIV and hepatitis viruses (HBV, HCV), and of blood donors and donations
Research and training in international transfusion safety

Murphy EL, Wang B, Sacher RA, Fridey J, Smith J, Nass C, Newman B, Ownby H, Garratty G, Hutching S, Schreiber GB. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-II and HTLV-I infection. Emerg Infect Dis 2004;10:109-116.
Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL. Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology 2004;1:4.
Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL. Long-term variation in HTLV-I and HTLV-II proviral load and association with clinical data. J Infect Dis (in press).
Gabet AS, Moules V, Sibon D, Nass CC, Mortreux F, Mauclere P, Gessain A, Murphy E, Wattel E. Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology 2006;33345:13-21.
Murphy EL, Reich P, Roberts P, Laabs N, Chinn A, McEvoy P, Hirschler N. A randomized trial of blood donor recruitment strategies. Transfusion 2006;46:1090-96.